Can a simple drug reduce retained placenta after pregnancy termination?
NCT ID NCT02969447
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving oxytocin after a second-trimester medical pregnancy termination helps prevent retained placenta. Twenty-seven women were randomly assigned to receive either oxytocin or no additional medication. The main goal was to see if oxytocin lowers the chance of needing further procedures to remove the placenta.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oxytocin
- What this could lead to
- If effective, this could provide a simple way to lower the chance of retained placenta after second-trimester pregnancy termination, reducing the need for additional procedures.
- What could go wrong
- This is a small, single-center trial with only 27 participants, so results may not apply broadly. The benefit may be modest or not statistically significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETAINED PLACENTA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Bordeaux
Bordeaux, 33076, France